Millions of Americans worry about the high costs of life-saving prescription drugs. That’s why 25 years ago, Congress created the 340B Drug Pricing Program to help hospitals expand access to prescription drugs and support essential services for our most vulnerable patients.

The program constitutes less than 3% of the more than $450 billion in U.S. annual drug purchases. Because it is funded by drug manufacturer discounts, not federal dollars, it doesn’t cost the government or taxpayers one penny – but it makes a big difference to patients.

We’re deeply disappointed in the Centers for Medicare & Medicaid Services’ recent decision to cut payments to hospitals participating in 340B that will put needed prescription drugs further out of reach, and dramatically threaten access to health care for many, including the uninsured, the elderly, those with chronic conditions and the disabled.

Contrary to the Administration’s claims, this policy change does nothing to address the stated goal of reducing the cost of pharmaceuticals, and would actually cause increases in some Medicare beneficiaries’ out-of-pocket costs.

We led the effort to circulate letters signed by a majority of both houses of Congress calling on the Administration to reconsider this policy and recognize the need for the 340B program to continue at full strength. CMS’ decision goes against the will of the Congress, and Congress must intervene to rein them in. We look forward to working with Congress to address this issue. Stay tuned for further updates.

The AHA will also be leading a coalition of other hospital groups and members to pursue litigation to prevent these draconian cuts to payments for 340B drugs from taking effect. We’ve heard from you, our members, how vital the 340B program is – and we’ll do whatever we can to defend it.

Please join our fight and contact your members of Congress and urge them to support 340B. This program must be protected so that hospitals can continue to provide quality care and services for the neediest patients.

Headline
The Centers for Medicare & Medicaid Services Oct. 23 released a proposed rule implementing new Health Insurance Marketplace eligibility verification…
Headline
The uninsured rate among working-age Americans rose to 11.2% in 2026, up from 8.9% in 2024, according to the latest biennial Commonwealth Fund survey on health…
Headline
Average annual premiums for employer-based family health coverage reached $28,303 in 2026, up 5% from 2025, according to the latest KFF annual survey on…
Headline
The Centers for Medicare & Medicaid Services Oct. 21 announced that Amazon, Axon Enterprise, Inc., Google, Meta and Oracle Corp. are in support of its…
Headline
The U.S. District Court for the District of Maine should deny motions by several drug companies and Pharmaceutical Research and Manufacturers of America to…
Headline
The Centers for Medicare & Medicaid Services Oct. 20 published two qualifying payment amount audits under the No Surprises Act. The audits were of…